80 Participants Needed

Short Walks to Break Up Sitting for Type 2 Diabetes

MO
sc
Overseen Bystudy coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment of breaking up sitting time with short walks for people with type 2 diabetes?

Research shows that breaking up long periods of sitting with light or moderate activity can help lower blood pressure in people at risk for type 2 diabetes. Additionally, a study found that reducing sitting time improved blood sugar control in people with type 2 diabetes.12345

Is breaking up sitting time with short walks safe for humans?

Research suggests that taking breaks from sitting with light to moderate activity, like short walks, is generally safe and can help lower blood pressure in people at risk for type 2 diabetes. However, more studies are needed to fully understand the long-term effects on vascular health.56789

How does the treatment of breaking up sitting time differ from other treatments for type 2 diabetes?

This treatment is unique because it focuses on reducing and interrupting prolonged sitting time with short walks, which can improve blood sugar control and reduce fatigue, unlike traditional treatments that primarily emphasize medication or intense exercise.4891011

What is the purpose of this trial?

Type 2 diabetes (T2D) confers a high risk of cardiovascular disease (CVD), particularly among older adults who tend to be physically inactive. Prolonged sedentary behavior (SB) has been shown to negatively influence markers of cardiovascular risk (e.g., blood glucose, blood pressure), even among individuals who are physically active. Most studies that have examined the effects of breaking up SB have focused on young healthy males and prioritized glycemic outcomes. Additionally, sex differences in these outcomes have not been adequately examined. The present study will address these gaps. This 3-arm crossover randomized controlled trial will compare the effects of 3 SB conditions on markers of vascular function. The 3 conditions are: 1) 4 hours of prolonged SB, 2) 4 hours of SB broken up by 5 minutes of self-paced walking every hour, and 3) 4 hours of SB with one 20-minute bout of self-paced walking. In addition to examining the overall effects of each condition, sex differences in physiological responses will be evaluated.

Research Team

MO

Mary O Whipple, PhD, RN, PHN

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for people over 60 with Type 2 diabetes who are mostly inactive, sitting for more than 6 hours a day. It's not for those on dialysis, with a history of DVT, unstable conditions, recent hormone therapy changes, meeting exercise guidelines, physical disabilities affecting movement, Type 1 diabetes or uncontrolled high blood pressure.

Inclusion Criteria

I have type 2 diabetes with an A1c of 6.5% or higher.
I can avoid food, caffeine, alcohol, exercise for 24 hours, and smoking for 12 hours before each visit.
I am a woman and have not had a period for at least 12 months.
See 3 more

Exclusion Criteria

You have trouble thinking and understanding things clearly, which could make it difficult for you to agree to participate in the study.
You are physically active for at least 150 minutes a week, measured using a questionnaire.
Your blood pressure is very high and not under control.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo 3 different sedentary behavior conditions to assess vascular function

12 weeks
Multiple visits for each condition

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • prolonged SB
  • SB broken 1
  • SB broken 2
Trial Overview The study tests how breaking up sitting time affects heart health in older adults with Type 2 diabetes. Participants will try three different routines: just sitting for four hours; walking five minutes every hour; and one longer walk of twenty minutes during the four hours.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: CONExperimental Treatment1 Intervention
Control group
Group II: BreakExperimental Treatment1 Intervention
Group III: BOUTExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

The study demonstrated that sedentary behavior counseling significantly reduced total sitting time from an average of 11.8 hours to 10.29 hours over three months in 10 adults with type 2 diabetes, indicating the intervention's effectiveness.
Participants also experienced a notable improvement in glycemic control, with a decrease in HbA1c levels by 0.51%, suggesting that reducing sedentary behavior can positively impact diabetes management.
Sedentary Behavior Counseling Intervention in Aging People With Type 2 Diabetes: A Feasibility Study.Alothman, S., Alenazi, AM., Alshehri, MM., et al.[2021]
A 24-week behavioral modification program using pedometers and telephone support significantly increased physical activity by an average of 2744 steps per day and reduced sedentary behavior by 23 minutes per day in type 2 diabetes patients.
These positive changes in physical activity and reduced sedentary time were still evident one year later, with an increase of 1872 steps per day and a decrease of 12 minutes in sedentary behavior, demonstrating the program's lasting impact.
The effects of a pedometer-based behavioral modification program with telephone support on physical activity and sedentary behavior in type 2 diabetes patients.De Greef, KP., Deforche, BI., Ruige, JB., et al.[2022]
In a study of 808 participants at high risk for type 2 diabetes, reallocating 30 minutes from sedentary behavior to light-intensity physical activity (LPA) led to significant reductions in waist circumference and glucose levels, indicating improved cardiometabolic health.
The most substantial benefits were observed when reallocating 30 minutes from sedentary behavior to moderate-to-vigorous intensity physical activity (MVPA), which resulted in greater reductions in waist circumference and glucose levels, highlighting the importance of higher intensity activities for health improvements.
Prospectively Reallocating Sedentary Time: Associations with Cardiometabolic Health.Yates, T., Edwardson, CL., Henson, J., et al.[2021]

References

Sedentary Behavior Counseling Intervention in Aging People With Type 2 Diabetes: A Feasibility Study. [2021]
The effects of a pedometer-based behavioral modification program with telephone support on physical activity and sedentary behavior in type 2 diabetes patients. [2022]
Prospectively Reallocating Sedentary Time: Associations with Cardiometabolic Health. [2021]
A randomised-controlled feasibility study of the REgulate your SItting Time (RESIT) intervention for reducing sitting time in individuals with type 2 diabetes: study protocol. [2021]
Acute effects of sedentary breaks on vascular health in adults at risk for type 2 diabetes: A systematic review. [2022]
Increasing Nonsedentary Behaviors in University Students Using Text Messages: Randomized Controlled Trial. [2018]
Too Little Exercise and Too Much Sitting: Inactivity Physiology and the Need for New Recommendations on Sedentary Behavior. [2022]
Sitting Less and Moving More: Improved Glycaemic Control for Type 2 Diabetes Prevention and Management. [2023]
A Randomised Controlled Trial to Reduce Sedentary Time in Young Adults at Risk of Type 2 Diabetes Mellitus: Project STAND (Sedentary Time ANd Diabetes). [2022]
Prolonged uninterrupted sitting increases fatigue in type 2 diabetes. [2019]
Sedentary behaviour as a new behavioural target in the prevention and treatment of type 2 diabetes. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security